Elliott Levy, MD

Venture Partner at5AM Ventures

Elliott Levy, MD, is a venture partner at 5AM Ventures and senior advisor at Boston Consulting Group. He has deep drug development experience from roles at Bristol Myers Squibb and Amgen, and serves on Terray Therapeutics' Scientific Advisory Board.

What Elliott can write

Writes checks ofNot reported
Comes in atSeed, Series ACan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Bristol Myers Squibb · senior vice president and head of specialty development
  2. Amgen · senior vice president of global development
  3. 5AM Ventures · venture partner
    Now
  4. Boston Consulting Group · Senior Advisor

Focus

drug developmentclinical trialssmall moleculeautoimmune

Education

Yale Medical School, graduated cum laude

Also at 5AM Ventures

Partners like Elliott

At firms with a similar stage, sector and check size.

Alert me when 5AM Ventures is active

One email when Elliott's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Elliott Levy, MD?

Elliott Levy, MD, is a venture partner at 5AM Ventures and senior advisor at Boston Consulting Group. He has deep drug development experience from roles at Bristol Myers Squibb and Amgen, and serves on Terray Therapeutics' Scientific Advisory Board.

How much does Elliott Levy, MD invest?

5AM Ventures has not reported a check size. It invests at seed, series a.

How do I pitch Elliott Levy, MD?

A warm intro from a founder 5AM Ventures backed works best.

What did Elliott Levy, MD do before 5AM Ventures?

senior vice president and head of specialty development at Bristol Myers Squibb; senior vice president of global development at Amgen; Senior Advisor at Boston Consulting Group.

Last updated 2026-10-15. Is this you? Ask for a correction.